đź“Š Evidence-Based Reference
via 17 microcatheter
Sequent Medical
Summary: The via 17 microcatheter is a device used primarily for venous stenting procedures. It has been FDA-cleared through the 510k pathway. Current evidence includes 10 studies, focusing on its clinical applications and safety profile.
FDA Clearance Information
Pathway
510K
Number
K162565 ↗
Decision Date
February 18, 2017
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The via 17 microcatheter, manufactured by Sequent Medical, was cleared by the FDA via the 510k pathway on February 18, 2017. It is classified as a Class 2 device under product code DQY.
What It Is
The via 17 microcatheter is a medical device designed for use in venous stenting procedures. It facilitates the delivery of stents to targeted venous locations, aiding in the treatment of vascular conditions.
Clinical Applications
This device is commonly used in procedures involving the placement of venous stents, particularly in cases where precise delivery and positioning of the stent are critical. It is utilized in various vascular interventions.
Evidence Summary
The available literature includes 10 studies, comprising various study types such as RCTs and case series, conducted between 2024 and 2025. These studies explore the device's clinical applications and safety.
Reported Outcomes
Published studies report that the via 17 microcatheter is effective in facilitating venous stenting procedures, with successful stent deployment in targeted areas. The device has shown reliability in clinical settings, contributing to improved procedural outcomes.
Safety Profile
Reported complications include procedural challenges related to catheterization techniques. However, no significant adverse events directly attributed to the device have been documented in the available studies.
Evidence Limitations
The evidence is limited by the small number of studies and the lack of large-scale randomized controlled trials. Further research is needed to establish long-term safety and efficacy, as well as to explore additional clinical applications.
Frequently Asked Questions
What are the clinical indications for via 17 microcatheter?
The via 17 microcatheter is indicated for use in venous stenting procedures, aiding in the delivery and placement of stents in vascular interventions.
What outcomes have been reported in clinical studies?
Clinical studies have reported successful stent deployment and improved procedural outcomes with the use of the via 17 microcatheter.
What complications have been reported?
Safety data indicate procedural challenges, but no significant adverse events directly linked to the device have been reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.